BIONET-ASIA CO., LTD.

Nature of Business: Manufacturer

Company Introduction:

BIONET-ASIA CO., LTD. is a prominent biopharmaceutical company based in Thailand, dedicated to the research, development, manufacturing, and distribution of human vaccines. The company operates advanced manufacturing facilities, including its significant plant located in Ayutthaya, Thailand. BIONET-ASIA is committed to enhancing global health by producing high-quality, safe, and effective vaccines for various infectious diseases. Their product portfolio encompasses established vaccines, and they actively engage in ongoing research for new vaccine candidates. Adhering to rigorous international quality and regulatory standards, BIONET-ASIA has established itself as a key manufacturer and innovator in the biopharmaceutical industry, with a core business model focused on proprietary production rather than solely trading.

BIONET-ASIA CO., LTD. Products

Manufactured Vaccines:

* **Pertagen** (Recombinant Acellular Pertussis Vaccine)

* **Boostagen** (Tetanus Toxoid, Reduced Diphtheria Toxoid, Recombinant Acellular Pertussis Vaccine)

* **BoostagenRED** (Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced Recombinant Pertussis Vaccine)

Imported and Distributed Vaccines:

* **TetraFlu** (Quadrivalent Influenza Vaccine)

* **bOPV** (Bivalent Oral Poliomyelitis Vaccine)

* **Healive** (Inactivated Hepatitis A Vaccine)

* **Bio-TT** (Tetanus Toxoid Vaccine)

* **Equirab** (Chromatographically Purified Rabies Immunoglobulin)

The company also develops and manufactures other innovative vaccines, particularly its Recombinant Pertussis Vaccines (RPV), and distributes a selection of other vaccines, including Polio, Rabies, and Hepatitis A.